Published in Cancer Res on April 05, 2011
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nat Genet (2014) 1.67
Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep (2012) 1.51
Down syndrome: searching for the genetic culprits. Dis Model Mech (2011) 1.28
2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin Cell Dev Biol (2013) 1.19
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos. Cell Div (2015) 1.07
Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nat Rev Cancer (2012) 1.01
MiR-1246: a new link of the p53 family with cancer and Down syndrome. Cell Cycle (2012) 0.98
Antioxidants in Down syndrome. Biochim Biophys Acta (2011) 0.85
The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series). Pulm Circ (2014) 0.83
Stem and progenitor cell dysfunction in human trisomies. EMBO Rep (2014) 0.79
Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1). Mamm Genome (2012) 0.79
Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice. Mech Dev (2014) 0.78
The use of mouse models for understanding the biology of down syndrome and aging. Curr Gerontol Geriatr Res (2012) 0.77
Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression. Dev Cell (2016) 0.75
Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment. PLoS One (2016) 0.75
Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APP. Front Behav Neurosci (2015) 0.75
Increased Skin Tumor Incidence and Keratinocyte Hyper-Proliferation in a Mouse Model of Down Syndrome. PLoS One (2016) 0.75
Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models. Epigenomics (2016) 0.75
A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet (1995) 4.95
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet (2000) 3.98
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature (2009) 3.93
Mouse models of tumor development in neurofibromatosis type 1. Science (1999) 3.40
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
Mouse tumor model for neurofibromatosis type 1. Science (1999) 2.89
Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature (2008) 2.71
Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood (2009) 2.17
Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem (2004) 2.05
Angiogenesis-dependent diseases. Semin Oncol (2001) 2.03
Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene (2003) 1.93
Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet (1993) 1.91
Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell (2008) 1.72
Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature (2010) 1.70
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci U S A (2004) 1.55
Leukemia in Down syndrome: a review. Pediatr Hematol Oncol (1992) 1.35
Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res (2004) 1.31
ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum Mol Genet (2003) 1.28
A tumor profile in Down syndrome. Am J Med Genet (1998) 1.26
Integration of cytogenetic with recombinational and physical maps of mouse chromosome 16. Genomics (1999) 1.18
High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours. Eur J Hum Genet (2001) 1.13
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner. Mamm Genome (2009) 1.11
The power of comparative and developmental studies for mouse models of Down syndrome. Mamm Genome (2007) 1.07
A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev (2008) 1.01
PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome. Biotechniques (2010) 0.98
Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis (2001) 0.90
Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis. Neurobiol Dis (2003) 0.86
The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37
Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature (2008) 2.71
Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res (2004) 2.29
Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res (2003) 1.93
Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum Mol Genet (2003) 1.80
Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci Transl Med (2013) 1.70
Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population. Circ Cardiovasc Genet (2012) 1.57
Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet (2007) 1.57
Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. Proc Natl Acad Sci U S A (2006) 1.47
The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci (2009) 1.46
Understanding the basis for Down syndrome phenotypes. PLoS Genet (2006) 1.41
Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am J Med Genet (2002) 1.39
Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock (2005) 1.35
Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res (2006) 1.31
Trisomy 21 and early brain development. Trends Neurosci (2011) 1.28
Development and validation of the Arizona Cognitive Test Battery for Down syndrome. J Neurodev Disord (2010) 1.15
Down syndrome: from understanding the neurobiology to therapy. J Neurosci (2010) 1.13
Genetic contribution to the septic response in a mouse model. Shock (2002) 1.08
Perinatal loss of Ts65Dn Down syndrome mice. Genetics (2005) 1.05
The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech (2011) 1.05
Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res (2002) 1.05
Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biol (2007) 1.04
A quantitative trait loci analysis to map genes involved in lipopolysaccharide-induced inflammatory response: identification of macrophage scavenger receptor 1 as a candidate gene. J Immunol (2006) 1.02
Effects of aneuploidy on skull growth in a mouse model of Down syndrome. J Anat (2007) 1.02
An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet (2012) 1.01
A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev (2008) 1.01
PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome. Biotechniques (2010) 0.98
Comparative genomic sequence analysis of the human chromosome 21 Down syndrome critical region. Genome Res (2002) 0.94
Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression. Mol Cancer (2005) 0.94
Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet A (2007) 0.93
Developmental aspects of the upper airway: report from an NHLBI Workshop, March 5-6, 2009. Proc Am Thorac Soc (2009) 0.92
The effects of piracetam on cognitive performance in a mouse model of Down's syndrome. Physiol Behav (2002) 0.91
A Sonic hedgehog (Shh) response deficit in trisomic cells may be a common denominator for multiple features of Down syndrome. Prog Brain Res (2012) 0.87
Microstructure of trabecular bone in a mouse model for Down syndrome. Anat Rec (Hoboken) (2007) 0.85
Down syndrome: national conference on patient registries, research databases, and biobanks. Mol Genet Metab (2011) 0.85
IL-10 plasma levels are elevated after LPS injection in splenectomized A/J mice. J Surg Res (2005) 0.82
Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice. Am J Med Genet A (2009) 0.82
Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment. J Neurosci (2013) 0.81
Protection from lethal endotoxic shock after testosterone depletion is linked to chromosome X. Shock (2005) 0.81
Increased male reproductive success in Ts65Dn "Down syndrome" mice. Mamm Genome (2010) 0.80
Allelic Interaction between CRELD1 and VEGFA in the Pathogenesis of Cardiac Atrioventricular Septal Defects. AIMS Genet (2014) 0.80
Trisomy 21 and facial developmental instability. Am J Phys Anthropol (2013) 0.79
Assessing cognitive improvement in people with Down syndrome: important considerations for drug-efficacy trials. Handb Exp Pharmacol (2015) 0.78
Morphological integration of soft-tissue facial morphology in Down Syndrome and siblings. Am J Phys Anthropol (2011) 0.78
Long-range chromosomal engineering is more efficient in vitro than in vivo. Transgenic Res (2005) 0.78
Functional genomics: a time and place for every gene. Nature (2002) 0.75
Meeting Report: 15th International Mouse Genome Conference. Mamm Genome (2002) 0.75
Genetic and comparative mapping of genes dysregulated in mouse hearts lacking the Hand2 transcription factor gene. Genomics (2002) 0.75